Correction: Corrigendum: PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA
Nature Communications 8: Article number: 15110 (2017); Published: 27 Apr 2017; Updated: 13 Jun 2017 In this Article, the antibody ‘BG4’ is consistently referred to incorrectly as ‘hf2’. These errors appear in the Results and Methods. Additionally, the Article incorrectly cites reference 52 in the se...
Main Authors: | Tovah A. Day, Jacob V. Layer, J. Patrick Cleary, Srijoy Guha, Kristen E. Stevenson, Trevor Tivey, Sunhee Kim, Anna C Schinzel, Francesca Izzo, John Doench, David E. Root, William C. Hahn, Brendan D. Price, David M. Weinstock |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms15918 |
Similar Items
-
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA
by: Tovah A. Day, et al.
Published: (2017-04-01) -
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
by: Yifan Wang, et al.
Published: (2019-12-01) -
Abstract P-18: PARP1-Induced Structural Rearrangements are Enhanced in Cisplatin-Treated Nucleosomes
by: Natalya Maluchenko, et al.
Published: (2019-06-01) -
Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer
by: Young Eun Choi, et al.
Published: (2016-01-01) -
Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
by: José Yélamos, et al.
Published: (2020-02-01)